Concourse Financial Group Securities, Inc. Chroma Dex Corp. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CDXC
# of Institutions
82Shares Held
16.4MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$11.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$10.5 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$4.6 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$4.02 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $243M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...